ARCHIVES

BMS, Exelixis To Collaborate On Drug Development.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Preyer Supported For Chairmanship

January 26, 1979

The Cancer Letter takes two-week break; next issue Jan. 2.

December 12, 2003

DRCA Planning Described; New Cancer Control Conference Set

February 4, 1983

NCI-Approved Protocols Listed

March 28, 2003

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994